The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Reder, Anthony T.
One or more keywords matched the following items that are connected to Reder, Anthony T.
Item TypeName
Concept Multiple Sclerosis, Relapsing-Remitting
Academic Article Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.
Academic Article Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Academic Article IFN-beta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactions.
Academic Article Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
Academic Article Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.
Academic Article Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
Academic Article Fingolimod for the treatment of relapsing multiple sclerosis.
Academic Article IFN-beta1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression.
Academic Article Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
Academic Article Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNß-1b trial.
Academic Article Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
Academic Article Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis.
Academic Article Treatment with interferon beta for multiple sclerosis.
Academic Article The effects of long-term interferon-beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study.
Academic Article Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Academic Article First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
Academic Article Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.
Academic Article The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis.
Academic Article Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
Academic Article Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.
Academic Article Early MRI results and odds of attaining 'no evidence of disease activity' status in MS patients treated with interferon ß-1a in the EVIDENCE study.
Academic Article Dimethyl fumarate-induced changes in the MS lymphocyte repertoire: No need for subset monitoring.
Academic Article Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.
Academic Article Real-world propensity score comparison of treatment effectiveness of peginterferon beta-1a vs. subcutaneous interferon beta-1a, glatiramer acetate, and teriflunomide in patients with relapsing-remitting multiple sclerosis.
Academic Article Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial.
Academic Article Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial.
Academic Article Novel biomarkers and interferon signature in secondary progressive multiple sclerosis.
Search Criteria
  • Multiple Sclerosis Relapsing Remitting